Miromatrix hits clinical milestone on path to scale organ transplants By: Minneapolis / St. Paul Business Journal via Business Journals October 12, 2021 at 15:57 PM EDT The successful nature of the transplants demonstrates the efficacy of bioengineered whole organs using the company's technology. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
